Path of least recurrence: A systematic review and <scp>meta‐analysis</scp> of fidaxomicin versus vancomycin for <i>Clostridioides difficile</i> infection-Reference-Cited by-同舟云学术

Path of least recurrence: A systematic review and meta‐analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection

Published:2022-11 Issue:11 Volume:42 Page:810-827
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Liao J. Xin¹²,Appaneal Haley J.¹²³^ORCID,Vicent Martie L.¹²,Vyas Ami²,LaPlante Kerry L.¹²³⁴^ORCID

Affiliation:

1. Infectious Diseases Research Program Providence Veterans Affairs Medical Center Providence Rhode Island USA

2. College of Pharmacy University of Rhode Island Kingston Rhode Island USA

3. Center of Innovation in Long‐Term Support Services Providence Veterans Affairs Medical Center Providence Rhode Island USA

4. Warren Alpert Medical School of Brown University Providence Rhode Island USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

Reference39 articles.

1. CDC.Antibiotic resistance threats in the United States 2019.2019. Accessed 2022‐03‐30T16:51:59Z.https://stacks.cdc.gov/view/cdc/82532

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献